|
medpundit |
||
 |
 |
|
Wednesday, January 04, 2006Two new studies deal a double blow to hopes that cholesterol-lowering statin drugs could help prevent cancer in addition to heart disease. In one report, researchers analyzed 26 rigorous, randomized studies involving more than 73,000 patients and concluded that drugs such as top-selling Lipitor and Zocor had no effect on the risk of developing or dying from any form of cancer. The findings appear in Wednesday's Journal of the American Medical Association. The other study, published in the Journal of the National Cancer Institute, found that cholesterol-lowering drugs, including statins, were of no benefit for preventing colorectal cancer. "We were very hopeful that we would verify there was an anti-cancer effect," said C. Michael White of the University of Connecticut School of Pharmacy, who led the analysis appearing in JAMA. "We ended up showing no change in cancer or cancer death." At least they didn't increase the risk of cancer, which has been a concern about them in the past. posted by Sydney on 1/04/2006 08:14:00 AM 0 comments 0 Comments: |
|
